---
figid: PMC9063966__PUL2-12-e12070-g005
pmcid: PMC9063966
image_filename: PUL2-12-e12070-g005.jpg
figure_link: /pmc/articles/PMC9063966/figure/pul212070-fig-0006/
number: Figure 6
figure_title: ''
caption: 'Survival analysis. The survival rates of the sham group, sham + CLP group,
  CLP group, and CLP + TPT group. *p < 0.05: CLP group versus sham group. #p < 0.05:
  CLP + TPT group versus CLP group. &p < 0.05: CLP + PDTC group versus CLP group.
  CLP, cecal ligation and puncture; PDTC, ammonium pyrrolidinedithiocarbamate; TPT,
  topotecan.'
article_title: Topotecan reduces sepsis‐induced acute lung injury and decreases the
  inflammatory response via the inhibition of the NF‐κB signaling pathway.
citation: Xiaoxia Wang, et al. Pulm Circ. 2022 Apr;12(2):e12070.
year: '2022'

doi: 10.1002/pul2.12070
journal_title: Pulmonary Circulation
journal_nlm_ta: Pulm Circ
publisher_name: John Wiley and Sons Inc.

keywords:
- acute lung injury
- cecal ligation and puncture
- inflammation
- NF‐κB
- topotecan

---
